NeuroSense Therapeutics Ltd. Basic Shares Outstanding (Weighted Average)
NeuroSense Therapeutics Ltd. (NRSN) reported Basic Shares Outstanding (Weighted Average) of 25.48 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-03-31
| Period end | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|
| 2025-12-31 | 25.48M shares 20-F · filed 2026-03-31 | |
| 2025-06-30 | 25.40M shares 6-K · filed 2025-08-01 | |
| 2024-12-31 | 18.60M shares 20-F · filed 2026-03-31 | |
| 2024-06-30 | 16.77M shares 6-K · filed 2025-08-01 | |
| 2023-12-31 | 13.64M shares 20-F · filed 2026-03-31 | |
| 2023-06-30 | 11.87M shares 6-K · filed 2024-09-30 | |
| 2022-12-31 | 11.50M shares 20-F · filed 2025-04-07 | |
| 2021-12-31 | 6.24M shares 6-K · filed 2024-06-17 |